B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Open Access
- 17 December 2012
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (1), 432-442
- https://doi.org/10.1172/jci65689
Abstract
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent, has become the first-line treatment for ITP; however, patients with refractory disease usually require splenectomy. We identified antibody-secreting cells as the major splenic B cell population that is resistant to rituximab. The phenotype, antibody specificity, and gene expression profile of these cells were characterized and compared to those of antibody-secreting cells from untreated ITP spleens and from healthy tissues. Antiplatelet-specific plasma cells (PC) were detected in the spleens of patients with ITP up to 6 months after rituximab treatment, and the PC population displayed a long-lived program similar to the one of bone marrow PC, thus explaining for most of these patients the absence of response to rituximab and the response to splenectomy. When analyzed by multiplex PCR at the single-cell level, normal splenic PC showed a markedly different gene expression profile, with an intermediate signature, including genes characteristic of both long-lived PC and proliferating plasmablasts. Surprisingly, long-lived PC were not detected in untreated ITP spleens. These results suggest that the milieu generated by B cell depletion promotes the differentiation and settlement of long-lived PC in the spleen.This publication has 47 references indexed in Scilit:
- Memory B and memory plasma cellsImmunological Reviews, 2010
- Effector and regulatory B cells: modulators of CD4+ T cell immunityNature Reviews Immunology, 2010
- Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritisProceedings of the National Academy of Sciences of the United States of America, 2010
- An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterizationBlood, 2009
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- Splenic macrophages maintain the anti‐platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpuraJournal of Thrombosis and Haemostasis, 2009
- Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 studyBlood, 2008
- Maintenance of the plasma cell pool is independent of memory B cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- SOCS3 Protein Developmentally Regulates the Chemokine Receptor CXCR4-FAK Signaling Pathway during B LymphopoiesisImmunity, 2007
- Depletion of B Cells in Murine Lupus: Efficacy and ResistanceThe Journal of Immunology, 2007